Amanote Research
Register
Sign In
Potential Factors Predicting the Response in the Treatment of Attention-Deficit/Hyperactivity Disorder Children With Atomoxetine in Asia Pacific Region
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.08.352
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2016
Authors
Y Chen
YL Zhang
X Zhang
SH Wu
Publisher
Elsevier BV
Related search
A Pilot Study of Atomoxetine in Young Children With Attention-Deficit/Hyperactivity Disorder
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
A Modelled Economic Evaluation Comparing Atomoxetine With Methylphenidate in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder in Spain
BMC Psychiatry
Psychiatry
Mental Health
Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children With Attention-Deficit/Hyperactivity Disorder
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Behavioural Response to Exercise in Children With Attention-Deficit/Hyperactivity Disorder
South African Journal of Sports Medicine
Behavioural Response to Exercise in Children With Attention-Deficit/Hyperactivity Disorder
South African Journal of Sports Medicine
Lisdexamfetamine in the Treatment of Adolescents and Children With Attention-Deficit/Hyperactivity Disorder
Adolescent Health, Medicine and Therapeutics
Effects of Atomoxetine on Growth in Children With Attention-Deficit/Hyperactivity Disorder Following Up to Five Years of Treatment
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Real-World Dosing Patterns of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder
CNS Neuroscience and Therapeutics
Psychiatry
Mental Health
Physiology
Pharmacology
Executive Function in Children With Attention Deficit/ Hyperactivity Disorder